Appropriate dosing of burosumab in tumor-induced osteomalacia

被引：3
|
作者：
Colangelo, Luciano [1 ]
Sonato, Chiara [1 ]
Riminucci, Mara [2 ]
Corsi, Alessandro [2 ]
Minisola, Salvatore [1 ]
机构：
[1] Sapienza Univ Rome, Dept Clin Internal Anesthesiol & Cardiovasc Sci, Rome, Italy
[2] Sapienza Univ Rome, Dept Mol Med, Rome, Italy
来源：
OSTEOPOROSIS INTERNATIONAL | 2022年 / 34卷 / 2期
关键词：
D O I：
10.1007/s00198-022-06617-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：421 / 421
页数：1
相关论文
共 50 条
  • [1] Appropriate dosing of burosumab in tumor-induced osteomalacia
    Luciano Colangelo
    Chiara Sonato
    Mara Riminucci
    Alessandro Corsi
    Salvatore Minisola
    Osteoporosis International, 2023, 34 : 421 - 421
  • [2] Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia
    Crotti, C.
    Zucchi, F.
    Alfieri, C.
    Caporali, R.
    Varenna, M.
    OSTEOPOROSIS INTERNATIONAL, 2022, 34 (2) : 423 - 424
  • [3] Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia
    C. Crotti
    F. Zucchi
    C. Alfieri
    R. Caporali
    M. Varenna
    Osteoporosis International, 2023, 34 : 423 - 424
  • [4] Burosumab for the Treatment of Tumor-Induced Osteomalacia
    Jan de Beur, Suzanne M.
    Miller, Paul D.
    Weber, Thomas J.
    Peacock, Munro
    Insogna, Karl
    Kumar, Rajiv
    Rauch, Frank
    Luca, Diana
    Cimms, Tricia
    Roberts, Mary Scott
    San Martin, Javier
    Carpenter, Thomas O.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2021, 36 (04) : 627 - 635
  • [5] Burosumab in Tumor-Induced Osteomalacia: A Case Report
    Carvalho, Erico
    Moraes, Juliana
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 127 - 128
  • [6] Burosumab in tumor-induced osteomalacia: A case report
    Paccou, Julien
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 215 - 216
  • [7] Burosumab in tumor-induced osteomalacia: A case report
    Day, Alvin Lee
    Gutierrez, Orlando M.
    Guthrie, Barton L.
    Saag, Kenneth G.
    JOINT BONE SPINE, 2020, 87 (01) : 81 - 83
  • [8] Burosumab for Tumor-Induced Osteomalacia: Not Enough of a Good Thing
    Hartley, Iris R.
    Collins, Michael T.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2021, 36 (12) : 2453 - 2454
  • [9] Reply to: Burosumab for Tumor-Induced Osteomalacia: not Enough of a Good Thing
    Jan de Beur, Suzanne M.
    Miller, Paul D.
    Weber, Thomas J.
    Peacock, Munro
    Insogna, Karl
    Kumar, Rajiv
    Rauch, Frank
    Luca, Diana
    Cimms, Tricia
    Roberts, Mary Scott
    Martin, Javier San
    Carpenter, Thomas O.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2021, 36 (12) : 2455 - 2456
  • [10] Long-term use of burosumab for the treatment of tumor-induced osteomalacia
    Crotti, C.
    Zucchi, F.
    Alfieri, C.
    Caporali, R.
    Varenna, M.
    OSTEOPOROSIS INTERNATIONAL, 2023, 34 (01) : 201 - 206
12345